evalution of effects of shigru and saindhava in pandu.

Pharmacotherapeutic Effect of Shigru (Moringa oleifera Lam.) And Saindhava in The Management of Pandu Roga (Iron Deficiency Anaemia) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083839

Enrollment

Registered

2025-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in clinical trial. 2. Patients between the age group 15 year to 60 years of either sex having cardinal symptoms of Pandu. 3. Patients having Hb% between 8 to 10 gm/dl 4. Pandu roga diagnosed according to objective parameters. 5. MCHC should be less than 34 g/dl 6. MCV should be less than 80fl

Exclusion criteria

Exclusion criteria: 1. Pregnant & lactating women. 2. Patient with age below 15yr. and above 60 yr. 3. Patients suffering from systemic diseases like renal disorders, heart disease, cancer, tuberculosis. 4. Patients having Hb % less than 8 gm/dl. 5. Any continuing blood loss e.g Haematemesis, melaena etc.

Design outcomes

Primary

Measure	Time frame
improvement in subjective and objective parametersTimepoint: improvement in subjective and objective parameters	—

Secondary

Measure	Time frame
To observe any side effects during clinical trialTimepoint: 45 days	—

Countries

India

Contacts

Public Contactprof dr chandan singh

PGIA, jodhpur

komaljhakal97@gmail.com9983959795

Outcome results